Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cymbalta in patients undergoing total knee arthroplasty
NCT03110172Phase 2Unknown
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Jan 2017
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 2, randomised trial of duloxetine in osteoarthritis of the knee (OA), sponsored by Dalian Municipal Central Hospital. Primary endpoints: Western Ontario and McMaster Universities Index Pain Score at 4 weeks and Knee Society Score Function Score at 4 weeks. Status: unknown.
02
Drugs
duloxetine
03
Conditions
osteoarthritis of the knee (OA)
Beyond the preview
Go deeper on NCT03110172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110172.